Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New concepts in infection/inflammation imaging.

H J Rennen1, F H Corstens, W J Oyen

  • 1Department of Nuclear Medicine, University Medical Center, Nijmegen, The Netherlands. H.Rennen@nugen.azn.nl

The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)
|July 31, 2001
PubMed
Summary

Nuclear medicine imaging for infection and inflammation is evolving beyond labeled leukocytes. New radiopharmaceuticals, including those used in positron emission tomography (PET), offer promising, less hazardous alternatives for detecting disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Imaging angiogenesis in patients with head and neck squamous cell carcinomas by [<sup>68</sup>Ga]Ga-DOTA-E-[c(RGDfK)]<sub>2</sub> PET/CT.

European journal of nuclear medicine and molecular imaging·2020
Same author

PET and SPECT imaging of a radiolabeled minigastrin analogue conjugated with DOTA, NOTA, and NODAGA and labeled with (64)Cu, (68)Ga, and (111)In.

Molecular pharmaceutics·2014
Same author

Targeted radionuclide and fluorescence dual-modality imaging of cancer: preclinical advances and clinical translation.

Molecular imaging and biology·2014
Same author

Monitoring hypoxia and vasculature during bevacizumab treatment in a murine colorectal cancer model.

Contrast media & molecular imaging·2014
Same author

Response to comment by Aprile et al.: the EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer.

European journal of nuclear medicine and molecular imaging·2014
Same author

Preoperative FDG-PET-scan in patients with resectable colorectal liver metastases does not improve overall survival: a retrospective analyses stratified by clinical risk score.

Digestive surgery·2014

Area of Science:

  • Nuclear Medicine
  • Radiopharmacology
  • Medical Imaging

Background:

  • Autologous leukocytes labeled with 111In or 99mTc are the gold standard for imaging infection and inflammation.
  • There is a need for less cumbersome and hazardous nuclear medicine techniques.
  • The development of novel radiopharmaceuticals is expanding the options for diagnosing infectious and inflammatory disorders.

Purpose of the Study:

  • To survey current and emerging radiopharmaceutical approaches for imaging infection and inflammation.
  • To highlight advancements in nuclear medicine for diagnosing inflammatory and infectious conditions.

Main Methods:

  • Review of radiolabeled agents including monoclonal antibodies, antibody fragments, chemotactic peptides, cytokines, and antibiotics.
  • Inclusion of positron emission tomography (PET) with 18F-FDG as a recent advancement.

Related Experiment Videos

  • Survey of radiopharmaceuticals in use and under investigation.

    • Main Results:

    • Various radiolabeled agents show promise for infection and inflammation imaging.
    • Positron emission tomography (PET) with 18F-FDG demonstrates high sensitivity in delineating infectious and inflammatory foci.
    • A growing range of radiopharmaceuticals are available for diagnostic applications.

    Conclusions:

    • Novel radiopharmaceuticals are expanding the field of nuclear medicine for infection and inflammation imaging.
    • Emerging techniques like PET offer improved diagnostic capabilities.
    • Continued research into radiopharmaceuticals promises safer and more effective diagnostic tools.